Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Venetoclax is a targeted anti-cancer drug used to treat certain types of blood c···【more】
Release date：2024-08-13Recommended：327
Venetoclax is a novel oral small molecule drug that targets the BCL-2 protein to···【more】
Release date：2024-08-13Recommended：419
Venetoclax is a small molecule drug that targets BCL-2 and is able to promote no···【more】
Release date：2024-08-13Recommended：308
Venetoclax is an oral anticancer drug targeting BCL-2 that promotes apoptosis of···【more】
Release date：2024-08-13Recommended：246
By binding to BCL-2 protein, venetoclax inhibits the obstruction of apoptosis of···【more】
Release date：2024-08-13Recommended：314
Venetoclax is a small molecule drug approved in combination with azacitidine for···【more】
Release date：2024-08-13Recommended：300
Venetoclax is an oral targeted drug that can effectively inhibit the anti-apopto···【more】
Release date：2024-08-13Recommended：367
Venetoclax is a targeted drug used in the treatment of a variety of hematologic ···【more】
Release date：2024-08-13Recommended：325
Venetoclax is the only approved selective inhibitor of Bcl-2 in the world. By bi···【more】
Release date：2024-08-13Recommended：312
As a potent and selective oral inhibitor targeting FGFR subtypes 1/2/3, Pemigati···【more】
Release date：2024-08-13Recommended：226
Pemigatinib, brand name Damitan, is a potent and selective oral inhibitor agains···【more】
Release date：2024-08-13Recommended：227
Pemigatinibis a small molecule kinase inhibitor targeting the fibroblast growth ···【more】
Release date：2024-08-13Recommended：308
